Biological Therapeutics Product Development Subject Matter Expert Consultants
ID: NIH-NINDS-CSS-75N95025Q00109Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Other Scientific and Technical Consulting Services (541690)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)
Timeline
  1. 1
    Posted Jan 2, 2025, 12:00 AM UTC
  2. 2
    Updated Jan 15, 2025, 12:00 AM UTC
  3. 3
    Due Jan 27, 2025, 6:00 AM UTC
Description

The National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), is seeking proposals for consulting services from subject matter expert (SME) consultants to support the development of biological therapeutics. The objective of this procurement is to engage SMEs who can provide technical recommendations across various phases of drug discovery and development, including chemistry, regulatory affairs, and clinical trial design, particularly for novel therapeutics aimed at neurological disorders and rare genetic conditions. This initiative is crucial for advancing NIH drug discovery programs and ensuring that innovative therapeutic solutions progress efficiently to clinical evaluation. Interested vendors must submit their proposals by January 27, 2025, and can direct inquiries to Shayna Simpson at shayna.simpson@nih.gov or Kelly Dempsey at kelly.dempsey@nih.gov. The contract is expected to span one year with two optional extensions, and the anticipated performance period is from April 1, 2025, to March 30, 2026.

Point(s) of Contact
Files
Title
Posted
Jan 15, 2025, 2:05 PM UTC
The document outlines questions and answers related to the solicitation for Biological Therapeutics Product Development subject matter expert (SME) consultants by the National Institutes of Health (NIH). The government is seeking multiple vendors, confirming it is not a sole-source procurement. Respondents may submit resumes for multiple SMEs without being constrained by the 10-page limit, as resumes are not included in this count. Regarding pricing, vendors can propose discount rates for key personnel by modifying the designated Excel price template, which allows for the addition of fully burdened labor rates. Furthermore, this solicitation is classified as a small business set-aside, promoting participation from small businesses in the bidding process. Overall, the document emphasizes the government's intent to broaden vendor participation while addressing specific submission guidelines for proposals.
Jan 15, 2025, 2:05 PM UTC
The National Institute of Neurological Disorders and Stroke (NINDS) seeks to contract high-level subject matter expert (SME) consultants for the translational development of biological therapeutics. This requirement aligns with NINDS's mission to advance research in neurological disorders and support NIH drug discovery programs, including the Blueprint Neurotherapeutics Network (BPN) and the Ultra-Rare Gene Therapy (URGenT) program. The consultants will provide critical insights across various phases of drug development, including chemistry, regulatory affairs, and clinical trial design, engaging in projects that aim to develop biologics, particularly for rare genetic disorders and pain therapeutics. The contract's performance period spans one year with two optional extensions, primarily conducted remotely with occasional on-site requirements. Consultants are expected to possess extensive experience in biologics development and be adept at navigating regulatory frameworks, including interactions with the FDA. Key deliverables include expert consultations, project milestone evaluations, and technical flow assessments. This initiative emphasizes the need for specialized guidance to enhance the efficiency and outcomes of NINDS's biologics development programs, ensuring that innovative therapeutic solutions progress to clinical evaluation successfully.
Jan 15, 2025, 2:05 PM UTC
The document outlines the additional terms and conditions relevant to the Federal Acquisition Regulation (FAR) provisions and clauses incorporated by reference into federal solicitations. It emphasizes the responsibilities of contractors in commercial product acquisitions, including requirements for the System for Award Management and various compliance standards, such as contractor ethics, tax regulations, and minority business utilization. Key clauses focus on maintaining equal opportunity initiatives, ensuring safety protocols, and adhering to regulations regarding labor standards and performance evaluations. The document also describes the role of the Contracting Officer and the procedure for contractor performance evaluations, ensuring oversight and accountability throughout the contract period. These provisions reinforce the federal government's commitment to transparency, fair competition, and compliance within procurement processes, particularly in light of current regulations and executive orders. Overall, the document serves as a critical resource for contractors and government agencies navigating federal contracting requirements.
Jan 15, 2025, 2:05 PM UTC
The document outlines provisions regarding telecommunications and video surveillance services or equipment for government offers, specifically referencing FAR 52.204-24 and the John S. McCain National Defense Authorization Act. It emphasizes that Offerors must assess their provision of "covered telecommunications equipment or services" and disclose whether they will provide such services to the government. Key definitions and prohibitions are established, notably Section 889(a)(1)(A), which bars the procurement of equipment that incorporates covered services. Offerors are required to review the System for Award Management for excluded entities and provide detailed disclosures if they do engage with covered equipment or services. The document also references salary rate limitations under HHSAR 352.231-70. Ultimately, this provision aims to ensure responsible contracting practices and compliance with national security regulations in telecommunications. The regulations highlight the federal government’s proactive stance to avoid reliance on potentially risky technologies in its contracts.
Jan 15, 2025, 2:05 PM UTC
The document outlines the pricing template for RFQ number 75N95025Q00109, which pertains to a government solicitation requiring consulting support. The government anticipates the involvement of 1-8 Subject Matter Experts (SMEs). It emphasizes the necessity for contractors to provide detailed pricing for standard and optional consulting support, as well as associated costs such as travel and other direct costs (ODCs). The document specifies the duration of the contract, set from April 1, 2025, to March 30, 2026, with two optional extension periods through 2028. It notes a projected travel expense of $1,500 per SME for up to three trips, alongside a total cost allocation for additional hours of consulting support. Overall, the purpose of the document is to facilitate contractors in submitting competitive and structured bids aligned with federal requirements for consulting services. Eligibility for additional costs is cautiously encapsulated, ensuring clarity in the submission process for potential bidders. This pricing structure is essential for transparency in federal contracting practices.
Jan 15, 2025, 2:05 PM UTC
The document outlines the technical evaluation criteria for a federal solicitation by the National Institutes of Health (NIH), specifically under the National Institute of Neurological Disorders and Stroke (NINDS). It details a two-phase evaluation process for quotes, emphasizing the importance of technical factors over price and past performance. Phase One evaluates the qualifications of quoters and their personnel based on their ability to fulfill the Statement of Work (SOW), with a scoring system out of 100 points. It also assesses the overall price for reasonableness and past performance with relevant projects. Phase Two involves oral presentations from the highest-rated quoters, focusing on technical understanding, communication skills, and their proposed approach to the project. The document includes specific evaluation criteria for technical factors such as personnel qualifications, understanding of project requirements, and presentation skills. It highlights the importance of demonstrating relevant experience, particularly in biotechnology and biologic discovery, as well as the need for effective communication among team members. Overall, the guidelines aim to ensure that the selected contractors are capable and knowledgeable to meet the project needs effectively.
Jan 15, 2025, 2:05 PM UTC
This document outlines the Invoice and Payment Provisions for federal contracts under the National Institutes of Health (NIH), detailing the process for submitting proper invoices and the timelines for payments. Key requirements for contractors include providing a well-documented invoice with specific information such as contractor details, invoice numbers, unique identifiers, and a description of the services rendered. The document specifies a 30-day payment window from the date an acceptable invoice is received or supplies are accepted. It also addresses interest penalties for late payments and the necessity for contractors to expedite payments to small business subcontractors within 15 days of receiving government payments. Moreover, the document mandates that invoices be submitted electronically through the Department of Treasury’s Invoice Processing Platform (IPP), with alternative submission methods only allowed under specific conditions. Overall, this document serves to standardize invoicing, streamline payments, and ensure compliance with federal regulations relating to contracts and payments.
The document outlines security provisions and requirements for a contract related to Bioactivity Assay Development Consultant Services, emphasizing the importance of safeguarding information and systems utilized by contractors working with the Department of Health and Human Services (HHS). Key points include compliance with specific FAR and HHSAR clauses on privacy, security safeguards, and personal identity verification, alongside mandatory IT security practices such as regular software updates, data encryption, and annual security training. Contractors must protect personally identifiable information (PII) and follow stringent incident response protocols in case of data breaches, including immediate reporting to relevant authorities. The document highlights the necessity for contractors to adhere to HHS standards for handling Controlled Unclassified Information (CUI) and outlines specific deliverables related to personnel security and incident response. This comprehensive security framework aims to ensure the confidentiality, integrity, and availability of sensitive government information throughout the duration of the contract, underscoring HHS's commitment to safeguarding its information systems and data.
Jan 15, 2025, 2:05 PM UTC
The National Institutes of Health (NIH) seeks proposals for consulting services to aid in the development of therapeutic biotechnology products (biologics) under solicitation number NIH-NINDS-CSS-75N95025Q00109. The objective is to engage subject matter experts (SMEs) with expertise across various aspects of drug development, covering the entire process from discovery through Phase 1 clinical trials. The solicitation primarily targets small businesses and encourages the submission of quotes under simplified acquisition procedures, with a potential contract type being a labor-hour purchase order. Consistent with the objectives of the NINDS, the consultants will provide technical recommendations on various key areas such as pharmacokinetics, toxicology, and regulatory affairs. The government plans to possibly engage between 1 to 10 SMEs, with work expected to be performed both remotely and at NIH facilities as needed. The contract consists of a one-year base period with two additional option years, and proposals must be submitted by January 27, 2025. Evaluation of bids will occur in phases, focusing on personnel qualifications, pricing, and past performance, leading to potential oral presentations from the top-rated quoters. Compliance with federal regulations, including salary limitations and past performance documentation, is mandatory.
Lifecycle
Title
Type
Combined Synopsis/Solicitation
Similar Opportunities
Toxicity testing on a new PET ligand for the NIH
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a toxicity testing service on a new PET ligand, Fluorine-18-Fluorocellobiose, as part of the requirements for an Investigational New Drug (IND) application to the FDA. The project entails conducting a single-dose toxicity study in Sprague Dawley rats to assess potential toxic effects, establish the maximum tolerated dose (MTD), and determine the no observable adverse effect level (NOAEL), all under Good Laboratory Practice (GLP) conditions. This initiative is crucial for advancing biomedical research and improving imaging techniques in the diagnosis and treatment of infectious diseases. Interested parties must submit their proposals by April 4, 2025, with the contract period expected to last for one year, and inquiries can be directed to Lu Chang at lu-chang.lu@nih.gov.
75N93025R00013 - Medical Residents for NIH's Clinical Center
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for the provision of Medical Residents at its Clinical Center in Bethesda, Maryland. The contract, structured as a Multiple Award Indefinite Quantity contract, aims to enhance clinical care for adult and pediatric inpatients involved in NIH research, requiring contractors to supply up to four postgraduate medical residents daily for a minimum of 80 hours per week. Proposals must be submitted by April 14, 2025, with a total funding range between $2,000 and $7,500,000 over the performance period from May 31, 2025, to May 30, 2030. Interested parties should direct inquiries to Sevag Kasparian or Maya Joseph via their provided emails for further clarification on the solicitation documents.
NULISAseq CNS Disease Panel 120 Kit or Equivalent
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information from qualified sources regarding the availability of the Alamar NULISAseq CNS Disease Panel 120 Kit or equivalent products. The objective is to procure three kits to aid in the investigation of biomarkers for neurodegenerative diseases, which are critical for early diagnosis and potential preventive measures. This procurement is essential for the NIH's Laboratory of Clinical Investigation, which focuses on isolating and measuring biomarkers from patient plasma to improve disease detection and management. Interested companies must submit their capability statements by April 11, 2025, to Eric McKay at eric.mckay@nih.gov, ensuring they include relevant details such as their business type and manufacturing information.
Extended Warranty and Technical Support for BBI-piPET-314-13
Buyer not available
The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking to award a sole source contract to Brain Biosciences, Inc. for extended warranty and technical support services for the BBI-piPET-314-13 primate PET scanner. The primary objective of this procurement is to ensure the continued high-quality imaging performance of the scanner, which is vital for conducting research on substance use disorders (SUD). This contract will include annual preventative maintenance, software updates, diagnostic services, and emergency repairs, all aimed at supporting critical research initiatives. Interested parties may submit their capabilities and proposals to Shaun Rostad at shaun.rostad@nih.gov, with responses due by the specified deadline, as this opportunity is set aside for small businesses under NAICS code 811210.
SOURCES SOUGHT: Signatures of aging outcomes
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small business contractors to perform comprehensive immunohistochemistry analysis of 2,184 mice tissue samples as part of a project aimed at identifying age-associated phenotypic changes in various organs. The objective is to build proteomic signatures of aging outcomes through detailed histological analysis, which includes tasks such as tissue trimming, cassette preparation, paraffin embedding, sectioning, staining, and imaging. This initiative is crucial for advancing the understanding of aging and its effects on health, and the selected contractor will be required to provide progress reports and deliver electronic images and stained slides within one year of sample receipt. Interested parties must submit their capability statements to Rashiid Cummins at rashiid.cummins@nih.gov by April 4, 2025, at 9:00 am Eastern Time, adhering to specified formatting guidelines.
Plasma assays of Alzheimer’s disease biomarkers (abeta42, abeta40, ptau217 ) using the Lumipulse assays on the Fujirebio G1200 in the Baltimore Longitudinal Study of Aging (BLSA)
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to perform plasma assays of Alzheimer’s disease biomarkers (abeta42, abeta40, ptau217) using Lumipulse assays on the Fujirebio G1200 for the Baltimore Longitudinal Study of Aging (BLSA). The contractor will analyze approximately 4,000 serum/plasma samples, employing senior research specialists to ensure continuity and consistency with prior assays, ultimately contributing to the understanding of cognitive decline and Alzheimer’s disease. This procurement is critical for advancing research on early identification and treatment of Alzheimer’s and related dementias, with a contract period anticipated from May 1, 2025, to April 30, 2026. Interested parties must submit their proposals by 9:00 a.m. EDT on April 11, 2025, to Emily Palombo at emily.palombo@nih.gov.
NHLBI Procurement Forecast - FY2025-Q1 & Q2
Buyer not available
The National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), has issued a special notice regarding its procurement forecast for the first and second quarters of Fiscal Year 2025. This notice outlines anticipated contracting opportunities, including a variety of goods and services such as scientific support services, IT security, and specialized scientific equipment, with a focus on fostering small business participation. The forecast serves as a planning tool for potential vendors, indicating that while the projected procurements are subject to change, they are essential for supporting the NIH's mission in health research. Interested parties can find detailed information, including estimated dollar values and points of contact, in the attached document, with initial award dates ranging from late 2024 to mid-2025.
Notice of Intent to Sole Source – TheraDoc subscription
Buyer not available
The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.
SOURCES SOUGHT: Maintenance and Repair Service for an Automated Liquid Handling System
Buyer not available
The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified small businesses to provide maintenance and repair services for a Microlab VANTAGE 1.3 Automated Liquid Handling System utilized by the National Institute on Aging (NIA) for neurodegenerative disease research. The procurement aims to ensure the system's continuous operation through preventative maintenance, repairs, and software updates, with a contract period spanning from June 17, 2025, to June 16, 2029, including options for extensions. This specialized maintenance support is critical for facilitating ongoing research efforts in Alzheimer's and related dementias, adhering to federal regulations and performance standards. Interested parties must submit their capability statements to Rashiid Cummins at rashiid.cummins@nih.gov by April 8, 2025, at 9:00 am Eastern Time.
National Institute on Aging Animal Care Support Services
Buyer not available
The National Institute on Aging (NIA), part of the Department of Health and Human Services, is seeking qualified small businesses to provide comprehensive animal care support services for its Intramural Research Program (IRP) focused on aging and related diseases. The contractor will be responsible for a range of services including animal husbandry, veterinary support, technical research assistance, and ensuring compliance with strict animal welfare standards at the Biomedical Research Center (BRC) in Baltimore, Maryland. This opportunity is critical for maintaining the integrity of research data and the humane treatment of laboratory animals, reflecting the NIA's commitment to rigorous scientific standards. Interested parties must submit their capability statements by April 17, 2025, to Emily Palombo at emily.palombo@nih.gov and Karen Mahon at karen.mahon@nih.gov, with a focus on demonstrating their qualifications and compliance with the specified requirements.